Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma-A network meta-analysis. Focus on cabozantinib combined with nivolumab

• Главные авторы: Maciej Niewada (Автор), Tomasz Macioch (Автор), Magdalena Konarska (Автор), Aneta Mela (Автор), Adam Goszczyński (Автор), Bogusława Przekopińska (Автор), Karolina Rajkiewicz (Автор), Piotr Wysocki (Автор), Maciej Krzakowski (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Introduction: The combination of immunotherapy and targeted therapy is currently marking a new era in the treatment of renal cancer. The latest clinical guidelines recommend the use of drug combinations for the first-line treatment of advanced renal cancer. The aim of this review is to compare the e...